Move faster from discovery to market. Operate more efficiently. Stay compliant.

Pharmaceutical and life sciences companies face enormous pressure to accelerate timelines and reduce cost — while operating in one of the most heavily regulated environments in the world. AI creates leverage at every stage when governed correctly.

What's keeping leadership up at night.

• Drug development timelines and costs that are unsustainable at current scale
• Commercial teams overwhelmed by data but under-equipped to act on it
• Pharmacovigilance and regulatory workloads growing faster than available capacity
• Pressure to demonstrate AI governance and responsible use to regulators and boards

Where AI creates measurable value.

01

Medical affairs content and literature synthesis

Use AI to synthesize scientific literature, generate MSL-ready content, and maintain up-to-date disease area knowledge — improving speed and consistency across medical affairs.

02

Pharmacovigilance case processing

Automate intake, triage, and narrative generation for adverse event reports — reducing manual processing time while maintaining compliance and audit readiness.

03

Commercial intelligence and field force optimization

Give sales and medical field teams AI-assisted insights on HCP targeting, territory planning, and next-best-action — improving commercial execution without increasing headcount.

04

Regulatory document preparation

Accelerate the drafting, review, and quality-checking of regulatory submissions using AI — reducing preparation time while improving consistency and traceability.

What measurable change looks like.

Growth

Faster commercial ramp, improved HCP engagement, and more effective medical affairs at lower cost.

Efficiency

Significant reduction in pharmacovigilance and regulatory document processing time.

Operating advantage

A compliant AI operating model that scales across functions without introducing regulatory or safety risk.

Proof points in this sector.

See how Quantum Rise applies QR/OS™ across workflows, governance, data, agents, adoption, and measurable business outcomes.

Machine Learning Sales Propensity Model for a Top 5 Global Pharma Company
Top 5 Global Pharmaceutical Company
Low prescriber base with limited ability to identify physicians who could and should prescribe the product, constrained by regulatory complexity and lack of analytical targeting capability.

Marketing Mix Modeling for a Top 5 Global Pharmaceutical Company
Top 5 Global Pharmaceutical Company
Marketing budget was allocated without a rigorous model of channel impact or saturation, making it impossible to maximise return across offline and digital marketing investments.

New Leads and Next Best Action for Sales Reps at a Top 5 Global Pharma Company
Top 5 Global Pharmaceutical Company
Sales reps lacked a reliable, data-driven way to identify untapped physicians or prioritise actions to increase engagement, resulting in inefficient deployment and missed prescribing opportunities.

How clients engage.

01 Pharmacovigilance automation assessment: identify volume, current process, and automation opportunity

02 Medical affairs AI readiness: evaluate content workflows, data assets, and governance requirements

03 Commercial AI diagnostic: assess field force data, tooling, and insight generation gaps

Use the tools. Build the operating model.

Many teams in this sector are already experimenting with AI tools. Quantum Rise helps turn those experiments into governed workflows, trained teams, and measurable business outcomes.

Governed workflows

Connect AI tools to real business workflows with the controls, oversight, and auditability that matter.

Trained teams

Role redesign, adoption support, and change leadership so people use AI tools to create real value.

Measurable outcomes

Track business impact, tool ROI, and performance improvements to justify investment and guide next steps.

Find the AI plays that matter in Pharma & Life Sciences.

We'll show you how QR/OS™ gets configured for your sector — and where the real value is.